Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
GHK-Cu acts as a physiological copper carrier in preclinical models, delivering copper into cells in a form that supports these enzymatic processes
doi: 10.1159/000182733 25 LittnerMKushidaCAAndersonWMBaileyDBerryRBDavilaDGet al
In this case, the active phase of VLEKT elaborated according to the KeNuT-SIE protocol [69] with replacement meals was prescribed for 28 days, at the end of which improvements in anthropometric measurements, body composition and metabolic parameters (reduction of total and LDL-cholesterol) were observed [14]
doi:10.3389/fnins.2020.576389 Li H, Toh PZ, Tan JY, et al
Tesofensine, a pharmaceutical compound under investigation for weight loss treatment, has shown promising results in clinical trials
US$ 21.38
US$ 29.84
US$ 25.62
US$ 24.02
US$ 24.87
